Evoke Pharma, Inc.

Shares of $EVOK are soaring today after the company received a Notice of Allowance from the United States Patent and Trademark Office for a patent application covering its gastroparesis treatment GIMOTI.

Share this article:

About the Author:

Evoke Pharma, Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup